Blog

Aruni Ghose: Collaboration with Dr. Swarupa Mitra on innovative cancer care

Aruni Ghose/LinkedIn

Jan 21, 2025, 05:44

Aruni Ghose: Collaboration with Dr. Swarupa Mitra on innovative cancer care

Aruni Ghose, Co-Founder and Chief Medical Officer of OncoFlow, posted the following on LinkedIn:

“It was more than a dream to be welcomed by one of India’s most sought-after radiation oncologists—an institution in herself—Dr. Swarupa Mitra at Fortis Memorial Research Institute – India.

What a pleasure to have worked together on:

177Lu-PSMA-617 in the Indian Prostate Cancer Setting (The Lancet Group)
Cervical Cancer Vaccination in the Indian setting (Society of Gynecologic Oncology)
Innovation in HPV Prevention Strategies (ecancer)

Delighted to be introduced to the whole team physically and virtually for the OncoFlow Platform Clinical Adoption and Implementation at the Fortis Cancer Institute and India-wide Fortis Group. Exciting times ahead!”

Aruni Ghose

Aruni Ghose cancer cancer innovation Cancer research cervical cancer clinical adoption Fortis Group Fortis Memorial Research Institute Gynecologic Oncology HPV Prevention India OncoDaily OncoFlow platform Oncology prostate cancer Swarupa Mitra

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer